Concepedia
Statistics
Publications
14
Citations
304
H-Index
11
Active since
2020
Affiliations
Fondazione IRCCS Istituto Nazionale dei Tumori(Current)
Istituti di Ricovero e Cura a Carattere Scientifico
University of Milan
Politecnico di Milano
University of Chicago
Sara Manglaviti is an author at Fondazione IRCCS Istituto Nazionale dei Tumori specializing in medicine, pathology, and oncology.
Top concepts
MedicineOncologyPathologyCancer TherapyImmunologyCancer ResearchLung CancerImmunotherapyRadiation OncologyMolecular Diagnostics
Publications per year
2020–2024
Poziotinib for EGFR and HER2 exon 20 insertion mutation in advanced NSCLC: Results from the expanded access program
Arsela Prelaj, Achille Bottiglieri, Claudia Proto et al. · European Journal of Cancer · 2021 · 57 citations
Advanced Nsclc, Genetic Disorder, Medicine +9
Machine Learning Using Real-World and Translational Data to Improve Treatment Selection for NSCLC Patients Treated with Immunotherapy
Arsela Prelaj, Mattia Boeri, Alessandro Robuschi et al. · Cancers · 2022 · 31 citations · Full text
Artificial Intelligence, Engineering, Machine Learning +23
Real-world data to build explainable trustworthy artificial intelligence models for prediction of immunotherapy efficacy in NSCLC patients
Arsela Prelaj, Edoardo Gregorio Galli, V. Miskovic et al. · Frontiers in Oncology · 2023 · 30 citations · Full text
Retreatment With Anti-EGFR Antibodies in Metastatic Colorectal Cancer Patients: A Multi-institutional Analysis
Daniele Rossini, Marco Maria Germani, Filippo Pagani et al. · Clinical Colorectal Cancer · 2020 · 26 citations
Medicine, Immunology, Anti-egfr Antibodies +7
STYLE (NCT03449173): A Phase 2 Trial of Sunitinib in Patients With Type B3 Thymoma or Thymic Carcinoma in Second and Further Lines
Claudia Proto, Sara Manglaviti, Giuseppe Lo Russo et al. · Journal of Thoracic Oncology · 2023 · 25 citations · Full text
Medicine, Thyroid Disease, Type B3 Thymoma +8
1–5 of 14